These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25055363)

  • 21. Does uremia cause vascular dysfunction?
    Brunet P; Gondouin B; Duval-Sabatier A; Dou L; Cerini C; Dignat-George F; Jourde-Chiche N; Argiles A; Burtey S
    Kidney Blood Press Res; 2011; 34(4):284-90. PubMed ID: 21691132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins].
    Bobot M
    Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications.
    Yamagami F; Tajiri K; Yumino D; Ieda M
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.
    Hoibian E; Florens N; Koppe L; Vidal H; Soulage CO
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions.
    Maciel RAP; Cunha RS; Busato V; Franco CRC; Gregório PC; Dolenga CJR; Nakao LS; Massy ZA; Boullier A; Pecoits-Filho R; Stinghen AEM
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30301260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiorenal syndrome: role of protein-bound uremic toxins.
    Lekawanvijit S; Krum H
    J Ren Nutr; 2015 Mar; 25(2):149-54. PubMed ID: 25556308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
    Lenglet A; Fabresse N; Taupin M; Gomila C; Liabeuf S; Kamel S; Alvarez JC; Drueke TB; Massy ZA
    Drugs; 2019 Jun; 79(8):855-862. PubMed ID: 31062264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
    Liabeuf S; Pepin M; Franssen CFM; Viggiano D; Carriazo S; Gansevoort RT; Gesualdo L; Hafez G; Malyszko J; Mayer C; Nitsch D; Ortiz A; Pešić V; Wiecek A; Massy ZA;
    Nephrol Dial Transplant; 2021 Dec; 37(Suppl 2):ii33-ii44. PubMed ID: 34718753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut microbiota and its relationship with chronic kidney disease.
    Plata C; Cruz C; Cervantes LG; Ramírez V
    Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship].
    Kiss I
    Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation, clearance, toxicity, and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions.
    Atherton JG; Hains DS; Bissler J; Pendley BD; Lindner E
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F890-F902. PubMed ID: 29537310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
    Fujii H; Goto S; Fukagawa M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review.
    Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal and pathologic concentrations of uremic toxins.
    Duranton F; Cohen G; De Smet R; Rodriguez M; Jankowski J; Vanholder R; Argiles A;
    J Am Soc Nephrol; 2012 Jul; 23(7):1258-70. PubMed ID: 22626821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The AKI-to-CKD Transition: The Role of Uremic Toxins.
    André C; Bodeau S; Kamel S; Bennis Y; Caillard P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis.
    van Ham WB; Cornelissen CM; van Veen TAB
    Acta Physiol (Oxf); 2022 Nov; 236(3):e13888. PubMed ID: 36148604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uremic toxins: some thoughts on acrolein and spermine.
    Sindhu KK
    Ren Fail; 2016 Nov; 38(10):1755-1758. PubMed ID: 27758122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease.
    Cupisti A; Piccoli GB; Gallieni M
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):71-79. PubMed ID: 31725009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.